Skip to main content
OpenTrials

Clinical trial condition

Stage III Fallopian Tube Cancer AJCC v7

Explore clinical trials studying Stage III Fallopian Tube Cancer AJCC v7. Study availability and eligibility vary by location and protocol.

8 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage III Fallopian Tube Cancer AJCC v7 trial results

Completed

Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02520154

Conditions
Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, +24 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02713386

Conditions
Adnexal Diseases, FIGO Stage III Ovarian Cancer 2014, FIGO Stage IIIA Ovarian Cancer 2014, +35 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Sutter Roseville Medical Center Roseville, California, United States
View all 110 locations
View Trial Details
Completed

Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02316834

Conditions
Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, +28 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • The Woman's Hospital of Texas Houston, Texas, United States
  • MD Anderson Regional Care Center-Katy Houston, Texas, United States
  • MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
View Trial Details
Completed

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01504126

Conditions
Adnexal Diseases, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Diseases, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Lyndon Baines Johnson General Hospital Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • The Woman's Hospital of Texas Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02659241

Conditions
Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, +34 more
Locations
  • OHSU Knight Cancer Institute Portland, Oregon, United States
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • Memorial Hermann Memorial City Medical Center Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

NCT01970722

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +43 more
Locations
  • City of Hope Corona Corona, California, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Upland Upland, California, United States
  • Parkview Hospital Randallia Fort Wayne, Indiana, United States
View Trial Details

Related conditions